WebPalleon researchers discovered the Achilles heel of sialoglycan-mediated immune evasion – all Siglec receptors that block the immune system depend on the presence of sialic acid. The EAGLE platform enables the development of therapeutics that strip sialic acid — the critical common dependency of this axis — from both cancer cells and ... WebInteractions between sialylated glycans and Siglec receptors have been recently described as potential new immune checkpoint that can be targeted to improve anticancer …
Targeting glyco-immune checkpoints for cancer therapy
WebJan 15, 2024 · The immunomodulatory sialoglycan–Siglec axis Cell surface glycans are often modified with terminal sialic acids that mediate many aspects of cell–cell interaction. In this sense, sialoglycans act as self-associated molecular patterns ( 23 ), and tumor cells commonly mask themselves by hypersialylating their surface glycans. WebApr 4, 2024 · Disturbing the Siglec-Sialoglycan axis to target myeloid- derived suppressor cells in the tumor microenvironment [abstract]. In: Proceedings of the American … chronic stomach pain in children
Tools to study and target the Siglec-sialic acid axis in cancer
WebDec 2, 2024 · Abstract. The sialic acid–binding immunoglobulin-like lectin (Siglec)–sialic acid immune axis is an evolutionarily conserved immunoregulatory pathway that provides a mechanism for establishing self-recognition and combatting invasive pathogens. Perturbations in the pathway lead to many immune dysregulated diseases, including … WebInterference with sialoglycan synthesis or sialoglycan–Siglec interactions might improve antitumor immunity. Many questions regarding specificity, signaling, and regulatory function of sialoglycan–Siglec interactions remain. We posit that sialoglycans and Siglecs present as potential glyco-immune ‘checkpoints’ for cancer immunotherapy. WebJan 27, 2024 · Antibodies targeting the sialoglycan-Siglec axis are already in clinical development. Other approaches with higher risk of toxicity including tumor-targeted sialidases are in late stage pre ... derivative accounting training